Headquarters
USA

Kailera Therapeutics

Kailera Therapeutics serves as a clinical-stage biopharmaceutical company focused on developing a portfolio of therapies for obesity and related conditions. The company offers a range of clinical and preclinical programs including injectable and oral peptides, as well as an oral small molecule, all designed to manage chronic weight conditions such as obesity and type 2 diabetes.

Quiénes somos

Participe en el Foro

Enlaces directos

Ediciones en otros idiomas

Política de privacidad y normas de uso

Sitemap

© 2025 Foro Económico Mundial